Oxazepine 150 Tablet DT contains Oxcarbazepine 150 mg, an anticonvulsant medication primarily indicated for the treatment of partial seizures in adults and children. Oxcarbazepine acts by stabilizing hyper-excited neuronal membranes, inhibiting repetitive neuronal firing, and reducing the propagation of synaptic impulses. This mechanism is achieved through the blockade of voltage-sensitive sodium channels, which decreases neuronal excitability. Oxazepine 150 Tablet DT is formulated as a dispersible tablet, allowing for ease of administration, particularly in patients who have difficulty swallowing conventional tablets. The medication is typically initiated at a low dose and titrated gradually to minimize adverse effects such as dizziness, somnolence, headache, nausea, and hyponatremia. Regular monitoring of serum sodium levels is recommended during therapy, especially in elderly patients or those with concomitant conditions predisposing to electrolyte imbalance. Oxcarbazepine is metabolized hepatically to its active metabolite, and dose adjustments may be necessary in hepatic or renal impairment. Oxazepine 150 Tablet DT should be used under medical supervision, with careful consideration of potential drug interactions, including other antiepileptic drugs and hormonal contraceptives. It is contraindicated in patients with hypersensitivity to oxcarbazepine or carbamazepine. This medication contributes significantly to seizure control and improved quality of life in patients with epilepsy.